Comparison of Basal (Fasting) Glycemic Control in Type 1 Diabetic Patients With CSII Achieved by the Circadian Slide Ruler Scale or Flat Basal Rate
NCT ID: NCT00569452
Last Updated: 2016-03-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2006-01-31
2006-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Flat and Circadian Insulin Infusion Rates in Continuous Subcutaneous Insulin Infusion
NCT04267770
A Monocenter, Open-Label Glucose Clamp Study Examining the Metabolic Effect of Insulin Infusion Intervals for Basal Insulin Infusion in Patients With Type I Diabetes
NCT00772356
Obtain a Good Blood Glucose Control With the Paradigm Real Time System
NCT00441129
Efficacy of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes Mellitus on Multiple Daily Injections (MDI) or Continuous Subcutaneous Insulin Infusion (CSII) Therapy
NCT01104142
A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump
NCT00115973
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Accu-Chek Spirit Insulin Pump
One basal rate
B
Accu-Chek Spirit Insulin Pump
Multiple basal rates
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Accu-Chek Spirit Insulin Pump
One basal rate
Accu-Chek Spirit Insulin Pump
Multiple basal rates
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Type 1 diabetes
* Diabetic for \>2 years, and treated with CSII for \>= 3 months
* HbA1c \<=8.5%
Exclusion Criteria
* Unstable chronic disease other than type 1 diabetes
* Severe hypoglycemic event within last week prior to study start
* Severe diabetic ketoacidosis within last month prior to study start
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hoffmann-La Roche
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andreas Buhr
Role: STUDY_DIRECTOR
Disetronic Medical Systems AG
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ulm, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DMS-01-CIRCADIAN-01
Identifier Type: -
Identifier Source: secondary_id
RD000278
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.